|
1）Shioi A. Vascular calicification. In: Morii H, et al. editors. Calcium in Internal Medicine. London: Springer-Verlag; 2002. p. 479-94
|
|
|
|
|
2）Stoneman VEA, Bennett MR. Role of apotosis in the atherosclerosis and its therapeutic implications. Clin Sci (London). 2004; 107: 343-54
|
|
|
|
|
|
3）Shioi A, Taniwaki H, Jono S, et al. Monckeberg's medial sclerosis and inorganic phoaphate in uremia. Am J Kidney Dis. 2001; 38: S47-9
|
|
|
|
|
4）Vattikuti R, Towler DA. Osteogenic regulation of vascular calcification: an early perspective. Am J Physiol Endocrinol Metab. 2004; 286: E686-96
|
|
|
|
|
|
5）Tanaka T, Sato H, Doi H, et al. Runx2 represses myocardin-mediated differentiation and facilitates osteogenic conversion of vascular smooth muscle cells. Mol Cell Biol. 2008; 28: 1147-60
|
|
|
|
|
|
6）Doi H, Iso T, Yamazaki M, et al. HERP1 inhibits myocardin-induced vascular smooth muscle cell differentiation by interfering with SRF binding to CArG box. Arterioscler Thromb Vasc Biol. 2005; 25: 2328-34
|
|
|
|
|
|
7）Iso T, Hamamori Y, Kedes L. Notch signaling in vascular development. Arterioscler Thromb Vasc Biol. 2003; 23(4): 543-53
|
|
|
|
|
|
8）Iso T, Chung G, Hamamori Y, et al. HERP1 is a cell type-specific primary target of Notch. J Biol Chem. 2002; 277: 6598-607
|
|
|
|
|
|
9）Doi H, Iso T, Sato H, et al. Jagged1-selective notch signaling induces smooth muscle differentiation via a RBP-J kappa-dependent pathway. J Biol Chem. 2006; 281: 28555-64
|
|
|
|
|
|
10）Shimizu T, Tanaka T, Iso T, et al. Notch signaling induces osteogenic differentiation and mineralization of vascular smooth muscle cells: role of Msx2 gene induction via Notch-RBP-Jk signaling. Arterioscler Thromb Vasc Biol. 2009; 29(7): 1104-11
|
|
|
|
|
|
11）Cheng SL, Shao JS, Charlton-Kachigian N, et al. MSX2 promotes osteogenesis and suppresses adipogenic differentiation of multipotent mesenchymal progenitors. J Biol Chem. 2003; 278: 45969-77
|
|
|
|
|
|
12）Nakagawa Y, Ikeda K, Akakabe Y, et al. Paracrine osteogenic signals via bone morphogenetic protein-2 accelerate the atherosclerotic intimal calcification in vivo. Arterioscler Thromb Vasc Biol. 2010; 30(10): 1908-15
|
|
|
|
|
|
13）Luo G, Ducy P, McKee MD, et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature. 1997; 386: 78-81
|
|
|
|
|
|
14）Collin-Osdoby P. Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin. Circ Res. 2004; 95: 1046-57
|
|
|
|
|
|
15）Doherty TM, Uzui H, Fitzpatrick LA, et al. Rationale for the role of osteoclast-like cells in arterial calcification. FASEB J. 2002; 16: 577-82
|
|
|
|
|
|
16）Bucay N, Sarosi I, Dunstan CR, et al. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev. 1998; 12: 1260-8
|
|
|
|
|
|
17）Atkinson J. Age-related medial elastocalcinosis in arteries: mechanisms, animal models, and physiological consequences. J Appl Physiol. 2008; 105: 1643-51
|
|
|
|
|
|
18）Son BK, Kozaki K, Iijima K, et al. Statins protect human aortic smooth muscle cells from inorganic phosphate-induced calcification by restoring Gas6-Axl survival pathway. Circ Res. 2006; 98: 1024-31
|
|
|
|
|
|
19）Jono S, McKee MD, Murry CE, et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res. 2000; 87(7): E10-7
|
|
|
|
|
|
20）Isakova T, Wahl P, Vargas GS, et al. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int. 2011; 79: 1370-8
|
|
|
|
|
|
21）Kuro-o M, Matsumura Y, Aizawa H, et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature. 1997; 390(6655): 45-51
|
|
|
|
|
|
22）Shimada T, Kakitani M, Yamazaki Y, et al. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest. 2004; 113(4): 561-8
|
|
|
|
|
|
23）Koh N, Fujimori T, Nishiguchi S, et al. Severely reduced production of klotho in human chronic renal failure kidney. Biochem Biophys Res Commun. 2001; 280: 1015-20
|
|
|
|
|
|
24）Hu MC, Shi M, Zhang J, et al. Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol. 2011; 22(1): 124-36
|
|
|
|
|
|
25）Shioi A, Katagi M, Okuno Y, et al. Induction of bone-type alkaline phosphatase in human vascular smooth muscle cells: roles of tumor necrosis factor-alpha and oncostatin M derived from macrophages. Circ Res. 2002; 91(1): 9-16
|
|
|
|
|
|
26）Lee HL, Woo KM, Ryoo HM, et al. Tumor necrosis factor-alpha increases alkaline phosphatase expression in vascular smooth muscle cells via MSX2 induction. Biochem Biophys Res Commun. 2010; 391: 1087-92
|
|
|
|
|
|
27）Csiszar A, Lehoux S, Ungvari Z. Hemodynamic forces, vascular oxidative stress, and regulation of BMP-2/4 expression. Antioxid Redox Signal. 2009; 11: 1683-97
|
|
|
|
|
|
28）Massy ZA, Stenvinkel P, Drueke TB. The role of oxidative stress in chronic kidney disease. Semin Dial. 2009; 22: 405-8
|
|
|
|
|